Recent activity indicates a mix of buy and sell transactions related to shares of the CVS Health Corporation. Several companies, notably Ossiam, Integral Health Asset Management, and Richard Bernstein Advisors, have reportedly sold off CVS shares, while numerous other firms such as Volterra Technologies, Invesco, and Capital Research Global Investors have purchased substantial quantities. There is perceptible buzz about CVS tapping into artificial intelligence via a partnership with Google Cloud to enhance the health platform. Allegations of Medicare fraud have seen CVS paying a settlement amount of $117.7M. Significant positions in CVS are held by firms like Arrowstreet Capital Limited Partnership and Watchtower Advisors. The CVS Health Foundation has also awarded $1 Million in Hometown Fund grants to boost local impact in Hartford, and CVS continues to extend its outreach with new Workforce Innovation and Talent Centers. The company's Q4 and full-year 2025 results have been reported, with the subsequent period witnessing share purchases and sales. Analysts have upgraded CVS health, and it is perceived to be a favourite among institutional investors. CVS has also been increasing corporate bonuses following record-high annual revenue.
Cvs Health Corporation CVS News Analytics from Thu, 26 Jun 2025 07:00:00 GMT to Sat, 14 Mar 2026 14:19:51 GMT - Rating 4 - Innovation 3 - Information 7 - Rumor -2
